🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sitaxsentan has a low drug-drug interaction potential and it did not have a...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01244620
Treatments Being Tested
As monotherapy for pulmonary arterial hypertension (PAH) begins to fail add...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-05
Trial ID
NCT00796666
Treatments Being Tested
This protocol is for subjects with pulmonary arterial hypertension and is t...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2008-12
Trial ID
NCT00795639
Treatments Being Tested
As sitaxsentan is the agent most highly selective for ETA (Endothelin Type ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT00796510
Treatments Being Tested